Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation-Reference-Cited by-同舟云学术

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

Published:2012-11-26 Issue:6 Volume:48 Page:837-842
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Basak G W, ,de Wreede L C,van Biezen A,Wiktor-Jedrzejczak W,Halaburda K,Schmid C,Schaap N,Dazzi F,von dem Borne P A,Petersen E,Beelen D,Abayomi A,Volin L,Buzyn A,Gurman G,Bunjes D,Guglielmi C,Olavarria E,de Witte T

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2012234.pdf

Reference21 articles.

1. Gratwohl A, Heim D . Current role of stem cell transplantation in chronic myeloid leukaemia. Best Pract Res Clin Haematol 2009; 22: 431–443.

2. Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A et al. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011; 46: 485–501.

3. Stem Cell Trialists’ Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074–5087.

4. Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD et al. Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006; 108: 4288–4290.

5. Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007; 13: 1461–1468.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era;The Egyptian Journal of Haematology;2022

2. Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies;Journal of Clinical Oncology;2021-02-10

3. Allogeneic haematopoietic stem cell transplantation with reduced-intensity conditioning in chronic myeloid leukaemia;Russian journal of hematology and transfusiology;2020-12-10

4. CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells;Cancer Research;2018-12-04

5. Hematopoietic Stem Cell Donor Selection and Graft-Versus-Host Disease;Chimerism;2018